Your browser doesn't support javascript.
loading
Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD.
Barraza-Flores, Pamela; Hermann, Hailey J; Bates, Christina R; Allen, Tyler G; Grunert, Timothy T; Burkin, Dean J.
Afiliação
  • Barraza-Flores P; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA.
  • Hermann HJ; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA.
  • Bates CR; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA.
  • Allen TG; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA.
  • Grunert TT; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA.
  • Burkin DJ; Department of Pharmacology, University of Nevada, Reno School of Medicine, Reno, NV, 89557, USA. dburkin@med.unr.edu.
Skelet Muscle ; 10(1): 18, 2020 06 04.
Article em En | MEDLINE | ID: mdl-32498713

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Laminina / Distrofias Musculares Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Laminina / Distrofias Musculares Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article